
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
N-Myc CRISPR/Cas9 KO Plasmid (m) | sc-421918 | 20 µg | $397.00 |
Mycn encodes the N-Myc transcription factor, a member of the MYC family that binds E-box motifs to regulate gene programs controlling cell-cycle progression, biosynthetic metabolism, ribosome biogenesis, and lineage determination during embryonic development. In mouse systems, N-Myc is critical for neural and mesenchymal progenitor expansion and coordinates signaling inputs from pathways such as PI3K–AKT–mTOR and MAPK to modulate proliferation and differentiation. Dysregulated MYCN activity is strongly linked to oncogenic transformation, altered chromatin state, and replication stress, making it a central node in studies of tumorigenesis and developmental biology. N-Myc-dependent networks also intersect with DNA damage responses and apoptosis, enabling mechanistic interrogation of growth control and cell fate decisions.
N-Myc CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Mycn gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Mycn together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Mycn open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish N-Myc protein expression.
This CRISPR knockout system enables efficient generation of Mycn-deficient cell models for investigation of N-Myc signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.